MAPT and Alzheimer disease: In addition, immunohistochemical analysis of hyperphosphorylated tau (PHF‐1) showed no differences in CA1 neuronal tau pathology between 3xTg‐AD‐vehicle and 3xTg‐AD‐HuCNS‐SC transplanted groups (Figs. 5F–H).